A Phase Iii, Partially Double-Blinded Study Evaluating The Efficacy And Safety Of Peginterferon Alfa-2a (40kd) (Pegasys (R)) Alone Or In Combination With Lamivudine Vs Lamivudine In 546 Patients With Hbeag-Negative/Anti-Hbe-Positive Chronic Hepatitis B.
Hepatology（2003）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要